Crossmark

HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells

Crossref DOI link: https://doi.org/10.1038/s41388-018-0227-y

Published Online: 2018-05-03

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

White, Matthew C.

Schroeder, Rebecca D.

Zhu, Keyi

Xiong, Katherine

McConkey, David J.
License Information

Text and Data Mining valid from 2018-05-03
More Information

Article History

Received: 9 April 2013

Revised: 26 October 2017

Accepted: 3 November 2017

First Online: 3 May 2018

Compliance with ethical standards

:

: David McConkey holds stock options with ApoCell, Inc.